NO20005668D0 - Forbindelser med veksthormonfrigjörende egenskaper - Google Patents

Forbindelser med veksthormonfrigjörende egenskaper

Info

Publication number
NO20005668D0
NO20005668D0 NO20005668A NO20005668A NO20005668D0 NO 20005668 D0 NO20005668 D0 NO 20005668D0 NO 20005668 A NO20005668 A NO 20005668A NO 20005668 A NO20005668 A NO 20005668A NO 20005668 D0 NO20005668 D0 NO 20005668D0
Authority
NO
Norway
Prior art keywords
compounds
growth hormone
hormone releasing
releasing properties
disubstituted
Prior art date
Application number
NO20005668A
Other languages
English (en)
Other versions
NO20005668L (no
NO318080B1 (no
Inventor
Thomas Kruse Hansen
Michael Ankersen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO20005668D0 publication Critical patent/NO20005668D0/no
Publication of NO20005668L publication Critical patent/NO20005668L/no
Publication of NO318080B1 publication Critical patent/NO318080B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrrole Compounds (AREA)
NO20005668A 1998-05-11 2000-11-10 4,4- og 3,3-disubstiterte piperidin-forbindelser med veksthormonfrigjorende egenskaper,farmasoytiske preparater som omfatter forbindelsene, samt anvendelse av forbindelsene eller preparatene til fremstilling av medikamenter NO318080B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK63698 1998-05-11
DKPA199800875 1998-07-01
PCT/DK1999/000260 WO1999058501A1 (en) 1998-05-11 1999-05-10 Compounds with growth hormone releasing properties

Publications (3)

Publication Number Publication Date
NO20005668D0 true NO20005668D0 (no) 2000-11-10
NO20005668L NO20005668L (no) 2001-01-10
NO318080B1 NO318080B1 (no) 2005-01-31

Family

ID=26064372

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005668A NO318080B1 (no) 1998-05-11 2000-11-10 4,4- og 3,3-disubstiterte piperidin-forbindelser med veksthormonfrigjorende egenskaper,farmasoytiske preparater som omfatter forbindelsene, samt anvendelse av forbindelsene eller preparatene til fremstilling av medikamenter

Country Status (23)

Country Link
EP (1) EP1077941B1 (no)
JP (2) JP4142253B2 (no)
KR (1) KR100593601B1 (no)
CN (1) CN1142911C (no)
AT (1) ATE439346T1 (no)
AU (1) AU757217B2 (no)
BR (1) BR9910329A (no)
CA (1) CA2329881C (no)
CY (1) CY1109626T1 (no)
CZ (1) CZ301276B6 (no)
DE (1) DE69941255D1 (no)
DK (1) DK1077941T3 (no)
ES (1) ES2331102T3 (no)
HU (1) HUP0102071A3 (no)
IL (2) IL139090A0 (no)
NO (1) NO318080B1 (no)
PL (1) PL194560B1 (no)
PT (1) PT1077941E (no)
RU (1) RU2243215C2 (no)
SI (1) SI1077941T1 (no)
TW (1) TWI222969B (no)
UA (1) UA72210C2 (no)
WO (1) WO1999058501A1 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001023376A1 (en) 1999-09-29 2001-04-05 Ortho-Mcneil Pharmaceutical, Inc. Isonipecotamides for the treatment of integrin-mediated disorders
UA73530C2 (uk) * 1999-11-10 2005-08-15 Ново Нордіск А/С Сполука з властивостями вивільнювати гормон росту
US20010020012A1 (en) * 2000-02-01 2001-09-06 Andersen Maibritt Bansholm Use of compounds for the regulation of food intake
WO2002046156A2 (en) 2000-12-06 2002-06-13 Sepracor, Inc. 4,4-disubstituted piperidines for use as dopamine, serotonin and norepinephrine ligands
EP1363631A4 (en) * 2001-03-02 2005-11-16 Bristol Myers Squibb Co "COMPOUNDS SUITED AS MODULATORS OF MELANOCORTIN RECEPTORS AND THESE PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF"
DE10113604A1 (de) * 2001-03-20 2002-10-24 Ibfb Gmbh Privates Inst Fuer B Verfahren zur Spaltung des humanen Wachstumshormons GH
US7081460B2 (en) 2001-04-09 2006-07-25 Ortho-Mcneil Pharmaceutical, Inc. Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders
US6911447B2 (en) 2001-04-25 2005-06-28 The Procter & Gamble Company Melanocortin receptor ligands
WO2003013571A1 (en) 2001-08-10 2003-02-20 Palatin Technologies, Inc. Peptidomimetics of biologically active metallopeptides
US7026335B2 (en) 2002-04-30 2006-04-11 The Procter & Gamble Co. Melanocortin receptor ligands
EP1407779A1 (en) 2002-10-10 2004-04-14 Gastrotech A/S Use of ghrelin for treating low body weight and body fat in gastrectomized individuals
US7132539B2 (en) 2002-10-23 2006-11-07 The Procter & Gamble Company Melanocortin receptor ligands
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
WO2005097261A1 (en) * 2004-03-30 2005-10-20 Sapphire Therapeutics, Inc. Method of reducing c-reactive protein using growth hormone secretagogues
WO2006016995A1 (en) * 2004-06-29 2006-02-16 Sapphire Therapeutics, Inc. Crystal forms of (3r)-1-(2-methylalanyl-d-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide
AU2005272598B2 (en) * 2004-08-12 2011-11-17 Helsinn Therapeutics (U.S.), Inc. Method of stimulating the motility of the gastrointestinal system using growth hormone secretagogues
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
JP2009542666A (ja) * 2006-06-30 2009-12-03 シェーリング コーポレイション Ｐ５３活性を増加させる置換ピペリジンおよびその使用
EP2644618B1 (en) 2007-02-09 2016-08-17 Ocera Therapeutics, Inc. tether intermediates for the synthesis of macrocyclic ghrelin receptor modulators
WO2012131090A1 (en) 2011-03-31 2012-10-04 Galderma Research & Development Method for treatment of xeroderma pigmentosum
CN114805305B (zh) * 2022-04-20 2024-04-26 成都诺和晟泰生物科技有限公司 一种化合物及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK56296A3 (en) * 1993-11-09 1997-02-05 Merck & Co Inc Piperidinal, pyrrolidinal and hexahydro-1h-azepinal derivatives, manufacturing process thereof and pharmaceutical compositions containing them
US5492916A (en) * 1993-12-23 1996-02-20 Merck & Co., Inc. Di- and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
US5721250A (en) * 1993-12-23 1998-02-24 Merck & Co. Inc. Di-and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
US5559128A (en) * 1995-04-18 1996-09-24 Merck & Co., Inc. 3-substituted piperidines promote release of growth hormone
WO1996035713A1 (en) * 1995-05-08 1996-11-14 Pfizer, Inc. Dipeptides which promote release of growth hormone
ES2235171T3 (es) * 1995-05-29 2005-07-01 Pfizer Inc. Dipeptidos que promueven la liberacion de la hormona de crecimiento.
GB2308064A (en) * 1995-10-31 1997-06-18 Merck & Co Inc Treatment of congestive heart failure with a growth hormone secretagogue
WO1997036873A1 (en) * 1996-04-03 1997-10-09 Merck & Co., Inc. Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
ATE304528T1 (de) * 1996-07-22 2005-09-15 Novo Nordisk As Verbindungen mit wachstumshormon-freisetzenden eigenschaften
AU4342097A (en) * 1996-09-13 1998-04-02 Merck & Co., Inc. Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
JP2001502319A (ja) * 1996-10-15 2001-02-20 藤沢薬品工業株式会社 成長ホルモンの放出を促進するベンズオキセピン誘導体

Also Published As

Publication number Publication date
RU2243215C2 (ru) 2004-12-27
AU757217B2 (en) 2003-02-06
EP1077941A1 (en) 2001-02-28
CY1109626T1 (el) 2014-08-13
DK1077941T3 (da) 2009-12-07
CZ20004129A3 (en) 2001-06-13
EP1077941B1 (en) 2009-08-12
IL139090A0 (en) 2001-11-25
BR9910329A (pt) 2001-01-30
CA2329881C (en) 2010-03-16
PL344042A1 (en) 2001-09-24
HUP0102071A3 (en) 2002-06-28
KR20010043422A (ko) 2001-05-25
WO1999058501A1 (en) 1999-11-18
TWI222969B (en) 2004-11-01
NO20005668L (no) 2001-01-10
HUP0102071A2 (hu) 2002-03-28
ATE439346T1 (de) 2009-08-15
PL194560B1 (pl) 2007-06-29
JP4938708B2 (ja) 2012-05-23
JP2008156372A (ja) 2008-07-10
DE69941255D1 (de) 2009-09-24
CA2329881A1 (en) 1999-11-18
PT1077941E (pt) 2010-07-01
AU3701099A (en) 1999-11-29
UA72210C2 (uk) 2005-02-15
JP4142253B2 (ja) 2008-09-03
CN1142911C (zh) 2004-03-24
KR100593601B1 (ko) 2006-06-28
NO318080B1 (no) 2005-01-31
IL139090A (en) 2007-03-08
JP2004500312A (ja) 2004-01-08
ES2331102T3 (es) 2009-12-21
CZ301276B6 (cs) 2009-12-30
SI1077941T1 (sl) 2010-01-29
CN1300281A (zh) 2001-06-20

Similar Documents

Publication Publication Date Title
DK1077941T3 (da) Forbindelser med væksthormonfrigörende egenskaber
ZA979961B (en) 5-HT1F agonists
ATE226947T1 (de) 2-substituierte 1,2,5-thiadiazolidin-3-on-1,1- dioxiden, zusammensetzung und deren verwendung
BG105256A (en) Muscarinic agonists and antagonists
BG103558A (en) Sulphonic acid or sulphonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
FI973221A0 (fi) 1-aryyli-2-asyyliammo-etaaniyhdisteitä ja niiden käyttö neurokiniiniantagonisteina, erityisesti neurokiniini 1 antagonisteina
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
SE9802937D0 (sv) Novel compounds
DK1100824T3 (da) Forbindelser med væksthormonfrigivende egenskaber
NO20012169D0 (no) Forbindelser med veksthormonfrigjörende egenskaper
EA199700032A1 (ru) Дезинфицирующий состав "велтолен"
PE61999A1 (es) Compuestos de tetrahidropiridina
MX9604201A (es) Nuevos derivados de piperidina.

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: HELSINN HEALTHCARE SA, CH

MK1K Patent expired